oral semaglutide trials Efficacy, safety and cardiovascular outcomes of once‐daily in patients with type 2 diabetes: The PIONEER programme - Thethi - 2020 - Diabetes, Obesity and Metabolism Now that oral semaglutide (#wegovy)

Switching from semaglutide to tirzepatide or vice versa without proper dose adjustment can lead to suboptimal blood sugar control or increased side effects such as nausea, vomiting, or hypoglycemia

However, the tirzepatide-based drug, garnering attention for its weight loss effects alongside Wegovy, "will only be introduced in the revised guideline as its domestic launch is still unclear," the society said

Contact your GP or mental health team immediately if you notice mood changes, sleep disturbances, increased anxiety, or thoughts of self-harm

Retatrutide is the first triple-agonist medication to complete Phase 2 trials for weight loss